Upcoming Webinars

Integrated Screening & Assay Capabilities Facilitate Peptide Drug Discovery

July 9, 2025

In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages, including high specificity, potent activity, and relatively low toxicity. Join our upcoming webinar on July 9th as we share strategies and methodologies in peptide discovery using DNA-encoded library (DEL) technology, phage display, and mRNA display, supported by corresponding case studies. We will also showcase our comprehensive bioassay platform and customized strategies for peptide ligand validation. Whether you're exploring peptide therapeutics for the first time or looking to expand your discovery toolkit, this webinar offers practical guidance and case studies to support your next breakthrough.

Register here

Preclinical Development, DMPK, and Bioanalytical Solutions for Peptides

July 10, 2025

Peptide therapeutics have garnered significant attention due to their remarkable potential in treating a wide range of human diseases, including diabetes, obesity, and cancer. However, the development of novel peptide therapeutics presents notable challenges. Their larger size and structural complexity pose unique difficulties in bioanalysis. Additionally, the diverse sub-modalities of therapeutic peptides result in distinct ADME properties, further complicating their preclinical development. Join our upcoming webinar on July 10th as we discuss non-clinical safety evaluation strategies, DMPK assessment, and ADME studies, as well as solutions for bioanalytical challenges, to provide researchers with essential knowledge and tools.

Register here